Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2002
10/24/2002WO2002083106A1 Controlled delivery of tetracycline compounds and tetracycline derivatives
10/24/2002WO2002083104A1 An effervescent solid composition of matter
10/24/2002WO2002083103A2 Pharmaceutical product with reticulated crystalline microstructure
10/24/2002WO2002083097A2 Drug delivery system for hydrophobic drugs
10/24/2002WO2002083096A1 Modification of the sustained release profile
10/24/2002WO2002083086A1 Pharmaceutical compositions of topic use, applied in treatment of skin and/or mucous injuries; use of compositions in treatment of skin and/or mucous injuries and use of compounds in treatment of skin and/or mucous injuries
10/24/2002WO2002083084A1 Nail compositions and methods of administering same
10/24/2002WO2002083079A2 Aerosol compositions containing formoterol for delivery to the lungs via nebulization
10/24/2002WO2002083076A2 Method for inhibiting atherosclerotic plaque formation
10/24/2002WO2002083060A2 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs
10/24/2002WO2002083058A2 Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers
10/24/2002WO2002083030A2 Bifunctional energy-reversible acyl-compositions
10/24/2002WO2002082930A1 Cactaceae-based formulation having the property of fixing fats, and method for obtaining same
10/24/2002WO2002082924A1 Microcapsules
10/24/2002WO2002066078A3 Modulated release particles for aerosol delivery
10/24/2002WO2002066077A3 Modulated release particles for aerosol delivery
10/24/2002WO2002062310B1 Multifunctional particulate additive for personal care and cosmetic compositions, and the process of making the same
10/24/2002WO2002048380A3 Glycosilated cationic lipids for liposomes used in drug delivery
10/24/2002WO2002047729A3 Drug delivery system comprising a drug intercalated between a layered double hidroxide
10/24/2002WO2002047667A3 Novel medicament compositions based on anticholinesterase drugs and on a steroid
10/24/2002WO2002044271A3 Surfactant-containing cosmetic, dermatological and pharmaceutical agents
10/24/2002WO2002032397A9 Electroprocessing in drug delivery and cell encapsulation
10/24/2002WO2002030467A3 Pharmaceutical composition containing honey for the treatment of wounds
10/24/2002WO2002015880A8 Powdered mannitol and mannitol-containing compositions
10/24/2002WO2002003972A3 Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
10/24/2002WO2002000210A3 Use of agents capable of reducing uric acid levels for the treatment of cardiovascular disease
10/24/2002WO2001076568B1 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
10/24/2002WO2001072315A9 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract
10/24/2002WO2001021135A3 Polymer conjugates of ara-c and ara-c derivatives
10/24/2002WO1999064449A3 Cell-permeable peptide
10/24/2002US20020156773 Soluble HLA ligand database utilizing predictive algorithms and methods of making and using same
10/24/2002US20020156529 Coating of nonhydroxyl- containing carbonated calcium phosphate bone mineral nanocrystalline apatite with adsorbed water; ring-shaped with central passageway
10/24/2002US20020156361 Positioning template for implanting a substance into a patient
10/24/2002US20020156318 N-methyl-L-alanine derivatives derivatives used for preparing cell binding agent/maytansinoid complexes
10/24/2002US20020156261 Wherein secondary structure disintegrates upon attachment of the oligonucleotide to a target nucleic acid; anticarcenogenic agents, treatment of Ewing's sarcoma
10/24/2002US20020156124 Paclitaxel, a solvent, a surfactant, a substituted cellulosic polymer, and a P-glycoprotein inhibitor; supersaturation of a microemulsion upon contact with water
10/24/2002US20020156099 1-acyl-piperidine substance p antagonist; used to treat central nervous system disorders and respiratory diseases
10/24/2002US20020156065 Medicament and method for the remediation of aberrant fibrotic tissue masses with topical calcium channel blocker preparations
10/24/2002US20020156062 Microaggregates of micelles containing phospholipids and a photosensitizer, and the phospholipids are capable of forming a lipid bilayer
10/24/2002US20020156047 Multi-arm block copolymers as drug delivery vehicles
10/24/2002US20020156037 DNA vaccine formulations
10/24/2002US20020156029 A kit for treating transient acantholytic dermatitis, acne miliaris necrotica, acne varioliformis, perioral dermatitis, or acneiform eruptions comprising, e.g., ivermectin, and a carrier
10/24/2002US20020156007 Apolipoprotein analogues
10/24/2002US20020155999 Method of using a porphyrin-like molecule conjugated with an anti-cancer drug for the treatment of cancer
10/24/2002US20020155996 Recombinant alpha-fetoprotein for treating cancers
10/24/2002US20020155995 Haptoglobin-haemoglobin complex or a part thereof or a mimic thereof being operably linked to a substance; capable of binding a CD163 receptor and/or a CD163 receptor variant.
10/24/2002US20020155992 Paclitaxel, epipodophyllotoxin, decetaxel, topotecan, and podophyllotoxin covalently conjugated to a polypeptide drug carrier having 50-90% by weight glutamic acid; inproved solubility
10/24/2002US20020155988 Uses of transport proteins
10/24/2002US20020155607 Multifunctional molecular complexes for gene transfer to cells
10/24/2002US20020155597 In vivo production and delivery of erthropoietin or insulinotropin for gene therapy
10/24/2002US20020155565 FAP-activated anti-tumor compounds
10/24/2002US20020155558 Generation of preferential phosphatides; obtain phosphatide, incubate with phosphatidyl glycerol, incubate phospholipase, recover phosphatide
10/24/2002US20020155498 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
10/24/2002US20020155496 Saturated and unsaturated abietane derivatives, derived conjugates and uses in a diagnostic composition, a reagent and a device
10/24/2002US20020155174 Acidified nitrite as an antimicrobial agent
10/24/2002US20020155158 For controlled, prolonged release of bioactive molecules such as therapeutic proteins, peptides and oligonucleotides
10/24/2002US20020155156 For forming controlled release formulation of a therapeutic agent; for coating solid dosage
10/24/2002US20020155154 Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
10/24/2002US20020155151 For therapy of diseases of the cardiovascular system, lung, muscles, stomach and bowels (ulcer and gastritis), diabetes, skin, nerves, tinnitus, in degenerative metabolic imbalance, incontinence, periodontosis, mitochondrial diseases
10/24/2002US20020155149 Iodophor compositions
10/24/2002US20020155145 Biofunctional polymers prepared in supercritical fluid
10/24/2002US20020155144 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
10/24/2002US20020155141 Pharmacologically acceptable solvent vehicles
10/24/2002US20020155129 Simple non-toxic system, deliverable by syringe or needle-free systems, is inexpensive and reliable and aids in parenteral drug delivery or mass immunization campaigns by reducing need for repeated injections
10/24/2002US20020155107 Methods and formulations for reducing circulating antibodies
10/24/2002US20020155102 Administering to a mammal formulation of cationic lipids and a substance that affects angiogenesis; allowing formulation to associate with angiogenic endothelial cells of an angiogenic blood vesselsuch that it enters cells
10/24/2002US20020155099 Transfer of molecules into the cytosol of cells
10/24/2002US20020155079 For use in cosmetics, pharmaceuticals, textile, printing, paper, leather, adhesives and agrochemical industry
10/24/2002US20020155076 Cosmetic or dermatological application
10/24/2002US20020155067 For drug delivery
10/24/2002US20020155066 For pulmonary administration of highly toxic or vesicating anticancer drugs
10/24/2002US20020153509 Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
10/24/2002DE10119338A1 Verwendung von Copolymerisaten auf Basis von Acrylamidoalkylsulfonsäuren als Verdicker in Zubereitungen enthaltend organische Lösemittel The use of copolymers based on acrylamidoalkylsulfonic as thickeners in preparations containing organic solvents
10/24/2002DE10116042A1 Exotoxin-Ligand Exotoxin-ligand
10/24/2002DE10061136C1 Stable, rapidly disintegrating tablets containing proton pump inhibitors, useful for treating elevated gastric secretion, comprising multiple drug units and auxiliaries including basic filler
10/24/2002CA2770489A1 Bisphosphonate conjugates and methods of making and using the same
10/24/2002CA2447008A1 Controlled delivery of tetracycline compounds and tetracycline derivatives
10/24/2002CA2446921A1 Selective covalent-binding compounds having therapeutic diagnostic and analytical applications
10/24/2002CA2444842A1 Toluene sulfonamide-containing anti-tumor composition and method of use thereof
10/24/2002CA2444518A1 Biomaterials comprising a melanocyte stimulating hormone (msh), and method of forming
10/24/2002CA2444421A1 Modification of the sustained release profile
10/24/2002CA2444267A1 Prodrugs of cox-2 inhibitors
10/24/2002CA2444262A1 Bifunctional energy-reversible acyl-compositions
10/24/2002CA2444253A1 Anilide and cyclodextrin complexes, their preparation and their use as medicine in particular for treating dyslipidemiae
10/24/2002CA2444220A1 Orally deliverable pharmaceutical composition comprising a drug of low water solubility (cox-2 inhibitor), a solvent, a fatty acid and an organic amine
10/24/2002CA2443968A1 Diagnosis and treatment of cancer: i
10/24/2002CA2443912A1 Vaccines including as an adjuvant type 1 ifn and processes related thereto
10/24/2002CA2443732A1 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs
10/24/2002CA2443563A1 Nail compositions and methods of administering same
10/24/2002CA2443473A1 3,7-diazabicyclo [3.3.1] formulations as anti-arrythmic compounds
10/24/2002CA2443471A1 An effervescent solid composition of matter
10/24/2002CA2443468A1 Pharmaceutical product with reticulated crystalline microstructure
10/24/2002CA2443464A1 3,7-diazybicyclo [3.3.1] formulations as antiarrhytmic compounds
10/24/2002CA2443242A1 Improvements in or relating to modified cellulose films
10/24/2002CA2443147A1 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
10/24/2002CA2443141A1 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002CA2443123A1 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
10/24/2002CA2442943A1 Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers
10/24/2002CA2433949A1 Compositions and methods for treating an arthritic condition
10/23/2002EP1251142A1 Use of copolymers based on acrylamidoalkylenesulphonic acid as thickener in compositions containing an organic solvent